These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 21145691)
1. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety. Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691 [TBL] [Abstract][Full Text] [Related]
2. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Rimondini R; Thorsell A; Heilig M Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor. Shoblock JR; Welty N; Nepomuceno D; Lord B; Aluisio L; Fraser I; Motley ST; Sutton SW; Morton K; Galici R; Atack JR; Dvorak L; Swanson DM; Carruthers NI; Dvorak C; Lovenberg TW; Bonaventure P Psychopharmacology (Berl); 2010 Feb; 208(2):265-77. PubMed ID: 19953226 [TBL] [Abstract][Full Text] [Related]
5. Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats. Badia-Elder NE; Stewart RB; Powrozek TA; Murphy JM; Li TK Alcohol Clin Exp Res; 2003 Jun; 27(6):894-9. PubMed ID: 12824809 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats. Caberlotto L; Thorsell A; Rimondini R; Sommer W; Hyytiä P; Heilig M Alcohol Clin Exp Res; 2001 Nov; 25(11):1564-9. PubMed ID: 11707630 [TBL] [Abstract][Full Text] [Related]
7. Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat. Morales-Medina JC; Dumont Y; Bonaventure P; Quirion R Neuropeptides; 2012 Dec; 46(6):329-34. PubMed ID: 23103057 [TBL] [Abstract][Full Text] [Related]
9. Effect of the adenosine A2a receptor antagonist 3,7-dimethyl-propargylxanthine on anxiety-like and depression-like behavior and alcohol consumption in Wistar Rats. Thorsell A; Johnson J; Heilig M Alcohol Clin Exp Res; 2007 Aug; 31(8):1302-7. PubMed ID: 17550371 [TBL] [Abstract][Full Text] [Related]
10. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374 [TBL] [Abstract][Full Text] [Related]
11. Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Thorsell A; Rimondini R; Heilig M Neurosci Lett; 2002 Oct; 332(1):1-4. PubMed ID: 12377370 [TBL] [Abstract][Full Text] [Related]
12. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219 [TBL] [Abstract][Full Text] [Related]
13. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat. Trent NL; Menard JL Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128 [TBL] [Abstract][Full Text] [Related]
14. Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats. Trent NL; Menard JL Physiol Behav; 2013 Feb; 110-111():20-9. PubMed ID: 23274501 [TBL] [Abstract][Full Text] [Related]
15. Food deprivation-like effects of neuropeptide Y on heroin self-administration and reinstatement of heroin seeking in rats. Maric T; Tobin S; Quinn T; Shalev U Behav Brain Res; 2008 Dec; 194(1):39-43. PubMed ID: 18639589 [TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors. Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209 [TBL] [Abstract][Full Text] [Related]
18. The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity. Walker MW; Wolinsky TD; Jubian V; Chandrasena G; Zhong H; Huang X; Miller S; Hegde LG; Marsteller DA; Marzabadi MR; Papp M; Overstreet DH; Gerald CP; Craig DA J Pharmacol Exp Ther; 2009 Mar; 328(3):900-11. PubMed ID: 19098165 [TBL] [Abstract][Full Text] [Related]
19. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain. Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419 [TBL] [Abstract][Full Text] [Related]
20. Neuropeptide YY(2)R blockade in the central amygdala reduces anxiety-like behavior but not alcohol drinking in alcohol-dependent rats. Kallupi M; Vendruscolo LF; Carmichael CY; George O; Koob GF; Gilpin NW Addict Biol; 2014 Sep; 19(5):755-7. PubMed ID: 23639035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]